Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1706180 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Runt-Related Transcription Factor 3 (RUNX3) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence at the C-terminal of human CSTA.Immunogen affinity purified.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Mutations in CSTA, encoding Cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion.
Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5.
Association analysis of cystatin A and zinc finger protein 148, two genes located at the psoriasis susceptibility locus PSORS5.
Blaydon DC, Nitoiu D, Eckl KM, Cabral RM, Bland P, Hausser I, van Heel DA, Rajpopat S, Fischer J, Oji V, Zvulunov A, Traupe H, Hennies HC, Kelsell DP
American journal of human genetics 2011 Oct 7;89(4):564-71
American journal of human genetics 2011 Oct 7;89(4):564-71
Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5.
Vasilopoulos Y, Walters K, Cork MJ, Duff GW, Sagoo GS, Tazi-Ahnini R
European journal of human genetics : EJHG 2008 Aug;16(8):1002-9
European journal of human genetics : EJHG 2008 Aug;16(8):1002-9
Association analysis of cystatin A and zinc finger protein 148, two genes located at the psoriasis susceptibility locus PSORS5.
Samuelsson L, Stiller C, Friberg C, Nilsson C, Inerot A, Wahlström J
The Journal of investigative dermatology 2004 Jun;122(6):1399-400
The Journal of investigative dermatology 2004 Jun;122(6):1399-400
No comments: Submit comment
No validations: Submit validation data